CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates CG Oncology Reports First Quarter 2024 Financial Results and Provides Business Updates

CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024 CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024

CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024 CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024